Clinical Trial Update: Phase 2 Study of TD-9855 to Treat Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 trial of TD-9855 in fibromyalgia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• TD-9855

Snippet

Sponsor: Theravance Biopharma | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2022-03-04